Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
Rhea-AI Summary
Emergent BioSolutions (NYSE: EBS), a public health company focused on protective and life-saving solutions, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. Joe C. Papa, the company's president and CEO, will deliver a presentation on Wednesday, January 15, 2025, at 1:30 PM PST.
The presentation will be accessible through an audio link, which will remain available for 30 days following the event. Additionally, the presentation slides will be published in the Investors section of Emergent's website coinciding with the presentation time.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, EBS declined 1.85%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
GAITHERSBURG, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions to communities across the world, today announced that Joe C. Papa, president and chief executive officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 1:30 PM PST.
The audio link for Emergent's session may be accessed here and will be live for up to 30 days.
The company’s slides will be made available at the time of the presentation on the Investors section of the Emergent website.
About Emergent BioSolutions
At Emergent, our mission is to protect and enhance life. For over 25 years, we’ve been at work defending people from things we hope will never happen—so we are prepared just in case they ever do. We provide solutions for complex and urgent public health threats through a portfolio of vaccines and therapeutics that we develop and manufacture for governments and consumers. We also offer a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how we help protect public health, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.
Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com
Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com
FAQ
When is Emergent BioSolutions (EBS) presenting at the J.P. Morgan Healthcare Conference 2025?
How long will the EBS presentation audio be available for listening?
Where can investors find EBS's J.P. Morgan Healthcare Conference presentation slides?
Who will represent EBS at the 2025 J.P. Morgan Healthcare Conference?
